United Kingdom Prospective Diabetes Study

From Citizendium
Revision as of 05:20, 3 December 2010 by imported>Robert Badgett
Jump to navigation Jump to search

In health care, the United Kingdom Prospective Diabetes Study (UKPDS) is a randomized controlled trial of the treatment of diabetes mellitus type 2.[1][2]

The UKPDS has created a clinical prediction rule.[3][4]

The study's website is at http://www.dtu.ox.ac.uk/ukpds_trial/.

references

  1. ↑ (1998) "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group". Lancet 352 (9131): 837–53. DOI:10.1016/S0140-6736(98)07019-6. PMID 9742976. Research Blogging. Review by ACP Journal Club
  2. ↑ (1998) "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.". Lancet 352 (9131): 854-65. PMID 9742977.
  3. ↑ Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group (2001). "The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).". Clin Sci (Lond) 101 (6): 671-9. PMID 11724655. [e]
  4. ↑ UKPDS Risk Engine
Retrieved from "https://citizendium.org/wiki/index.php?title=United_Kingdom_Prospective_Diabetes_Study&oldid=814847"